Genomic cancer testing enables comprehensive analysis of cancer susceptibility and progression at the molecular level. These tests examine genetic variations and mutations to determine risk of cancer development and select optimal targeted therapies. They aid in early detection of cancer and development of customized treatment plans based on patient's genetic profile.
The global Genomic Cancer Testing Market is estimated to be valued at US$ 18.61 million in 2024 and is expected to ... Read more
